Clinical trials are a very important part of the research process. New treatments, medications and medical devices cannot be approved for use in Australia without going through clinical trials. Find out more about clinical trials.
Amlitelimab (KY1005) for moderate to severe atopic dermatitis
A clinical trial to assess a new drug called amlitelimab (KY1005) as a treatment for moderate to severe atopic dermatitis (eczema)
Assessing a new tablet for plaque psoriasis
Understanding the effect of medication on the body's inflammatory response may lead to new treatments for autoimmune conditions, including psoriasis.
The research study is testing an investigational product called TAVO101 designed specifically for people diagnosed with moderate to severe atopic dermatitis (eczema),
Benralizumab for moderate to severe atopic dermatitis
A clinical trial to assess the safety and effectiveness of a new drug called benralizumab for atopic dermatitis (eczema).
Benralizumab for the treatment of bullous pemphigoid
A research project to measure how safe and effective benralizumab is in treating participants with bullous pemphigoid (BP).
Bimekizumab for the treatment of moderate to severe hidradenitis suppurativa
In this study, we tested whether bimekizumab helps people with a skin disease called hidradenitis suppurativa.
Bitopertin as a treatment for erythropoietic protoporphyria
Research project to measure how safe and effective bitopertin (DISC-1459) is in treating participants with erythropoietic protoporphyria.
This study aims to assess efficacy and safety of JNJ-77242113 compared to placebo and ustekinumab in people with moderate to severe Plaque Psoriasis.
Efgartigimod for the treatment of pemphigus vulgaris or pemphigus foliaceous
A clinical trial to assess how safe and effective the study drug. efgartigimod, is in treating participants with pemphigus who are also receiving oral corticosteroids.
KPL-716 to reduce pruritus in people with prurigo nodularis
A clinical trial to assess a new drug (KPL-716) for prurigo nodularis (PN).
Ligelizumab for chronic spontaneous urticaria
A clinical trial to assess a new drug called ligelizumab for the treatment of chronic spontaneous urticaria (CSU).
Nemolizumab for the treatment of moderate to severe atopic dermatitis
A clinical trial to assess safety and effectiveness of a new drug for eczema called nemolizumab.
New blood test to diagnose and monitor autoimmune blistering skin conditions
A prospective study on serum antibodies against target antigens of bullous autoimmune diseases and genetic susceptibility.
New drug for basal cell carcinoma
A study to assess the safety and efficacy of ASN-002 combined with a hedgehog pathway inhibitor (vismodegib) in the treatment of multiple low-risk basal cell carcinomas in sporadic or basal cell naevus syndrome patients.
New drug for moderate to severe hidradenitis suppurativa
A clinical trial to assess the safety and effectiveness of a new drug for hidradenitis suppurativa.
New treatment for moderate-to-severe plaque psoriasis
Treatments that are highly selective in inhibiting the body's immune response have the potential to increase quality of life for people with plaque psoriasis.
This study aims to understand how effective and safe a study therapy is for people with hidradenitis suppurativa (HS), how it affects their daily lives, and how it may help to improve their overall health and wellbeing.
Remibrutinib for chronic spontaneous urticaria
A clinical trial to assess a new drug for chronic spontaneous urticaria (CSU) not controlled with antihistamine medication or omalizumab (Xolair®) in the past.
Ritlecitinib in adults with non-segmental vitiligo
This trial is investigating a medication for treating people living with non-segmental vitiligo.
Spesolimab for the treatment of generalised pustular psoriasis
A study to test whether spesolimab prevents flare-ups in patients with generalised pustular psoriasis.
Spesolimab for the treatment of hidradenitis suppurativa
A study to measure how safe and effective spesolimab (the study drug) is in treating participants with moderate to severe hidradenitis suppurativa (HS).
Trial to assess a new tablet for plaque psoriasis
Plaque psoriasis is an autoimmune condition characterised by dry, itchy and scaly skin patches. This trial investigates whether people with plaque psoriasis may be able to take an oral treatment to improve the condition.
Understanding antigen triggers in psoriasis
A non-interventional study to investigate triggers in psoriasis.